{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T12:25:59Z","timestamp":1780143959780,"version":"3.54.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jgisurgery.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gastrointestinal Surgery"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.gassur.2025.102133","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T12:01:49Z","timestamp":1750939309000},"page":"102133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy of neoadjuvant therapy in gallbladder cancer: a meta-analysis using reconstructed time-to-event data"],"prefix":"10.1016","volume":"29","author":[{"given":"Sean","family":"Loke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen Ee","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedict Ding Chao","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunlin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred Wei Chieh","family":"Kow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Hao","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.gassur.2025.102133_bib1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1479-666X(08)80073-X","article-title":"Gallbladder cancer \u2014 a comprehensive review","volume":"6","author":"Lai","year":"2008","journal-title":"Surgeon"},{"issue":"5","key":"10.1016\/j.gassur.2025.102133_bib2","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(18)30915-X","article-title":"Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study","volume":"20","author":"Primrose","year":"2019","journal-title":"Lancet Oncol"},{"issue":"15","key":"10.1016\/j.gassur.2025.102133_bib3","article-title":"Association of Neoadjuvant chemotherapy on survival in locally advanced gallbladder cancer","volume":"38","author":"Kazmi","year":"2020","journal-title":"J Clin Oncol"},{"issue":"49","key":"10.1016\/j.gassur.2025.102133_bib4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/jncimonographs\/lgu024","article-title":"Cancer survival: an overview of measures, uses, and interpretation","volume":"2014","author":"Mariotto","year":"2014","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"2","key":"10.1016\/j.gassur.2025.102133_bib5","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","article-title":"The clavien-Dindo classification of surgical complications: five-year experience","volume":"250","author":"Clavien","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.gassur.2025.102133_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.suronc.2024.102096","article-title":"Preventing futile surgery in intrahepatic and perihilar cholangiocarcinomas: can we identify preoperative factors to improve patient selection and optimize outcomes?","volume":"55","author":"Goel","year":"2024","journal-title":"Surg Oncol"},{"issue":"1","key":"10.1016\/j.gassur.2025.102133_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2288-12-9","article-title":"Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves","volume":"12","author":"Guyot","year":"2012","journal-title":"BMC Med Res Method"},{"key":"10.1016\/j.gassur.2025.102133_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102870","article-title":"Effectiveness of immune checkpoint inhibitors and other treatment modalities in patients with advanced mucosal melanomas: a systematic review and individual patient data meta-analysis","volume":"77","author":"Teo","year":"2024","journal-title":"EClinicalMedicine"},{"issue":"24","key":"10.1016\/j.gassur.2025.102133_bib9","doi-asserted-by":"crossref","first-page":"5887","DOI":"10.3390\/cancers15245887","article-title":"Non-Vitamin K antagonist oral anticoagulants versus low molecular weight heparin for cancer-related venous thromboembolic events: individual patient data meta-analysis","volume":"15","author":"Yau","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"10287","key":"10.1016\/j.gassur.2025.102133_bib10","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/S0140-6736(21)00591-2","article-title":"Association of metabolic\u2013bariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective controlled studies with 174\u2009772 participants","volume":"397","author":"Syn","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.gassur.2025.102133_bib11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.12688\/wellcomeopenres.14738.1","article-title":"The development and evaluation of an online application to assist in the extraction of data from graphs for use in systematic reviews","volume":"3","author":"Cramond","year":"2018","journal-title":"Wellcome Open Res"},{"issue":"2","key":"10.1016\/j.gassur.2025.102133_bib12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0895-4356(99)00161-4","article-title":"Publication bias in meta-analysis: its causes and consequences","volume":"53","author":"Thornton","year":"2000","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.gassur.2025.102133_bib13","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.gassur.2025.102133_bib14","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.hpb.2018.03.008","article-title":"Outcome of neoadjuvant chemotherapy in \u201clocally advanced\/borderline resectable\u201d gallbladder cancer: the need to define indications","volume":"20","author":"Chaudhari","year":"2018","journal-title":"HPB"},{"key":"10.1016\/j.gassur.2025.102133_bib15","doi-asserted-by":"crossref","first-page":"1511583","DOI":"10.3389\/fonc.2024.1511583","article-title":"Efficacy of neoadjuvant therapy and lymph node dissection in advanced gallbladder cancer without distant metastases: a SEER database analysis","volume":"14","author":"Dong","year":"2024","journal-title":"Front Oncol"},{"issue":"9","key":"10.1016\/j.gassur.2025.102133_bib16","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1245\/s10434-016-5197-0","article-title":"Neoadjuvant chemoradiation followed by surgery for locally advanced gallbladder cancers: a new paradigm","volume":"23","author":"Engineer","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.gassur.2025.102133_bib17","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s00280-015-2908-3","article-title":"Evaluation of the safety and pathological effects of neoadjuvant full-dose gemcitabine combination radiation therapy in patients with biliary tract cancer","volume":"76","author":"Kobayashi","year":"2015","journal-title":"Cancer Chemother Pharmacol"},{"issue":"3","key":"10.1016\/j.gassur.2025.102133_bib18","doi-asserted-by":"crossref","first-page":"368","DOI":"10.4103\/ijc.IJC_822_19","article-title":"Predictors of toxicity after neoadjuvant chemoradiotherapy for locally advanced gall bladder cancer","volume":"59","author":"Loyal","year":"2022","journal-title":"Indian J Cancer"},{"key":"10.1016\/j.gassur.2025.102133_bib19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.sopen.2024.08.001","article-title":"Analysis of neoadjuvant therapy effect on 30-day postoperative outcomes in gallbladder cancer","volume":"21","author":"Martin","year":"2024","journal-title":"Surg Open Sci"},{"issue":"2","key":"10.1016\/j.gassur.2025.102133_bib20","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.46912","article-title":"A propensity score analysis of chemotherapy use in patients with resectable gallbladder cancer","volume":"5","author":"Ozer","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"10","key":"10.1016\/j.gassur.2025.102133_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2023.107035","article-title":"Lessons learnt from 1300 consecutive gallbladder cancer surgeries: evolving role of peri-operative chemotherapy in the treatment paradigm","volume":"49","author":"Patkar","year":"2023","journal-title":"Eur J Surg Oncol"},{"issue":"11","key":"10.1016\/j.gassur.2025.102133_bib22","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.1245\/s10434-021-09687-4","article-title":"Revision surgery for incidental gallbladder cancer-challenging the dogma: ideal timing and real-world applicability","volume":"28","author":"Patkar","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.gassur.2025.102133_bib23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s13193-015-0377-0","article-title":"Resection after neoadjuvant chemotherapy in advanced carcinoma of the gallbladder: a retrospective study","volume":"6","author":"Selvakumar","year":"2015","journal-title":"Indian J Surg Oncol"},{"issue":"6","key":"10.1016\/j.gassur.2025.102133_bib24","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1007\/s12664-021-01182-8","article-title":"Combination of portal vein embolization and neoadjuvant chemotherapy for locally advanced gallbladder cancer requiring extended hepatectomy \u2013 a novel approach","volume":"40","author":"Singh","year":"2021","journal-title":"Indian J Gastroenterol"},{"issue":"10","key":"10.1016\/j.gassur.2025.102133_bib25","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.2217\/fon.14.308","article-title":"Neoadjuvant chemotherapy in patients with locally advanced gallbladder cancer","volume":"11","author":"Sirohi","year":"2015","journal-title":"Future Oncol"},{"key":"10.1016\/j.gassur.2025.102133_bib26","doi-asserted-by":"crossref","DOI":"10.1177\/10732748241271682","article-title":"Prognostic impact of neoadjuvant chemotherapy in localized or Locoregionally advanced gallbladder cancer: a population-based and propensity score matched SEER analysis","volume":"31","author":"Xiong","year":"2024","journal-title":"Cancer Control"},{"issue":"7","key":"10.1016\/j.gassur.2025.102133_bib27","doi-asserted-by":"crossref","first-page":"694","DOI":"10.6004\/jnccn.2023.0035","article-title":"NCCN Guidelines\u00ae insights: biliary tract cancers, version 2.2023","volume":"21","author":"Benson","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"issue":"4","key":"10.1016\/j.gassur.2025.102133_bib28","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/SLA.0000000000000728","article-title":"Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer: an international multicenter study","volume":"261","author":"Shindoh","year":"2015","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.gassur.2025.102133_bib29","first-page":"120","article-title":"Evidence for resection of colorectal liver metastases","volume":"2","author":"Aloia","year":"2006","journal-title":"Curr Colorectal Cancer Rep"},{"issue":"2","key":"10.1016\/j.gassur.2025.102133_bib30","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejso.2018.08.020","article-title":"The role of neoadjuvant chemotherapy or chemoradiotherapy for advanced gallbladder cancer \u2013 a systematic review","volume":"45","author":"Hakeem","year":"2019","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"10.1016\/j.gassur.2025.102133_bib31","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3390\/cancers13030547","article-title":"Validation of the 8th edition American Joint Commission on Cancer (AJCC) gallbladder cancer staging system: prognostic discrimination and identification of key predictive factors","volume":"13","author":"Giannis","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"10391","key":"10.1016\/j.gassur.2025.102133_bib32","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/S0140-6736(23)00727-4","article-title":"Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"401","author":"Kelley","year":"2023","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.gassur.2025.102133_bib33","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200015","article-title":"Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer","volume":"1","author":"Oh","year":"2022","journal-title":"NEJM Evid"},{"issue":"5","key":"10.1016\/j.gassur.2025.102133_bib34","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/hep.30493","article-title":"Integrative analysis defines distinct prognostic subgroups of intrahepatic cholangiocarcinoma","volume":"69","author":"Goeppert","year":"2019","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.gassur.2025.102133_bib35","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s11864-016-0432-2","article-title":"Genomic profiling of biliary tract cancers and implications for clinical practice","volume":"17","author":"Jain","year":"2016","journal-title":"Curr Treat Options Oncol"},{"issue":"5","key":"10.1016\/j.gassur.2025.102133_bib36","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.jhep.2020.11.033","article-title":"Integrative molecular characterisation of gallbladder cancer reveals micro-environment-associated subtypes","volume":"74","author":"Nepal","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.gassur.2025.102133_bib37","doi-asserted-by":"crossref","first-page":"S216","DOI":"10.1016\/j.annonc.2023.09.1390","article-title":"97P neoadjuvant durvalumab plus gemcitabine and cisplatin (D+GemCis) versus gemcis alone for localized biliary tract cancer (BTC): results of a randomized, multicenter, open-label, phase II trial (DEBATE)","volume":"34","author":"Yoo","year":"2023","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.gassur.2025.102133_bib38","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-028147","article-title":"A phase III randomised clinical trial of perioperative therapy (neoadjuvant chemotherapy versus chemoradiotherapy) in locally advanced gallbladder cancers (POLCAGB): study protocol","volume":"9","author":"Engineer","year":"2019","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.gassur.2025.102133_bib39","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12885-020-6610-4","volume":"20","author":"Goetze","year":"2020","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.gassur.2025.102133_bib40","doi-asserted-by":"crossref","first-page":"TPS621","DOI":"10.1200\/JCO.2023.41.4_suppl.TPS621","article-title":"Randomized multicenter phase III trial of neoadjuvant gemcitabine + cisplatin + S-1 (GCS) versus surgery first for resectable biliary tract cancer (JCOG1920: NABICAT)","volume":"41","author":"Nara","year":"2023","journal-title":"J Clin Oncol"}],"container-title":["Journal of Gastrointestinal Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X25001921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X25001921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T21:54:19Z","timestamp":1755122059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091255X25001921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1091255X25001921"],"URL":"https:\/\/doi.org\/10.1016\/j.gassur.2025.102133","relation":{},"ISSN":["1091-255X"],"issn-type":[{"value":"1091-255X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of neoadjuvant therapy in gallbladder cancer: a meta-analysis using reconstructed time-to-event data","name":"articletitle","label":"Article Title"},{"value":"Journal of Gastrointestinal Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gassur.2025.102133","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Society for Surgery of the Alimentary Tract. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102133"}}